FDA and EMA Accept Regulatory Submission for Pfizer's Ritlecitinib for Individuals 12 Years ...

Retrieved on: 2022-09-11 08:36:23

Tags for this article:

Click the tags to see associated articles and topics

FDA and EMA Accept Regulatory Submission for Pfizer's Ritlecitinib for Individuals 12 Years .... View article details on hiswai:

Excerpt

Filings based on clinical data demonstrating significant scalp hair regrowth versus placebo –. NEW YORK, NY, USA I September 09, 2022 IPfizer Inc.

Article found on: pipelinereview.com